Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Preferred Stock Liabilities (2023 - 2025)

Historic Preferred Stock Liabilities for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 3 years, with Q2 2025 value amounting to $46.1 million.

  • Lifecore Biomedical, Inc. \De\'s Preferred Stock Liabilities rose 824.2% to $46.1 million in Q2 2025 from the same period last year, while for May 2025 it was $46.1 million, marking a year-over-year increase of 824.2%. This contributed to the annual value of $46.1 million for FY2025, which is 824.2% up from last year.
  • Latest data reveals that Lifecore Biomedical, Inc. \De\ reported Preferred Stock Liabilities of $46.1 million as of Q2 2025, which was up 824.2% from $45.2 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Preferred Stock Liabilities registered a high of $46.1 million during Q2 2025, and its lowest value of $38.5 million during Q1 2023.
  • For the 3-year period, Lifecore Biomedical, Inc. \De\'s Preferred Stock Liabilities averaged around $42.2 million, with its median value being $42.2 million (2024).
  • Its Preferred Stock Liabilities has fluctuated over the past 5 years, first soared by 833.79% in 2024, then skyrocketed by 824.2% in 2025.
  • Over the past 3 years, Lifecore Biomedical, Inc. \De\'s Preferred Stock Liabilities (Quarter) stood at $40.9 million in 2023, then grew by 8.28% to $44.3 million in 2024, then grew by 4.03% to $46.1 million in 2025.
  • Its last three reported values are $46.1 million in Q2 2025, $45.2 million for Q1 2025, and $44.3 million during Q4 2024.